![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, January 15, 2013 11:36:02 PM
Canaccord raises their GNMK tgt to $14 from $12. Given mgmt's recent track record of executing, coupled with its long-term growth trajectory, firm believes GNMK merits trading at the upper end of the MDx peer group P/S multiple (5x-7x). Given the strong start to the flu season, GNMK should see good results from its RVP test. CDC indicated that 7.3% of all deaths resulted from pneumonia and influenza, crossing the "epidemic" threshold of 7.2%.
Read more: http://www.briefing.com/InPlayEq/InPlay/InPlayDual.htm#ixzz2I3SHr07T
Under Creative Commons License: Attribution
Follow us: @Briefingcom on Twitter | Briefingcom on Facebook
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM